Biotechnology/Pharmaceutical Services Outsourcing Market Analysis, By Service And Segment Forecasts, 2014 - 2025

  • ID: 4031946
  • Report
  • Region: Global
  • 137 pages
  • Grand View Research
1 of 6

FEATURED COMPANIES

  • Concept Heidelberg GmbH
  • Management Forum
  • Quality Context Ltd.
  • QuintilesIMS
  • The Quantic Group
  • MORE
The global biotechnology services outsourcing market is expected to reach USD 92.9 billion by 2025, according to this new report. Pharmaceutical industry has been adaptive of the function of outsourcing certain clinical and corporate functions as early as 2002. Among the services outsourced, clinical trial management and contract manufacturing were the forerunners. For instance, Johnson & Johnson was the first pharmaceutical company to outsource its applications development and maintenance (ADM).

In 2015, over USD 50.0 billion was spent on pharmaceutical R&D activities majorly on oncology, diabetes, and autoimmune therapy classes, which is expected to propel the biotechnology services outsourcing market growth over the forecast period.

Shrinking profit margins coupled with rising competition in the market space, and augmenting regulatory burden are other vital impact rendering factors. The pharmaceutical services outsourcing market is expected to register growth at a CAGR of 8.7% during the forecast period. On the other hand, pending immigration legislations in the U.S. may hinder business economics and outsourcing risks.

Pharmaceutical and biotechnology industries in Europe are significantly investing in R&D in the recent year owing to rising demand for advanced medicines. This may be attributed to increasing aging population, incidence of chronic diseases, and communicable diseases.

Further key findings from the study suggest:

Consulting services are inclusive of regulatory compliance, remediation, and quality management systems consulting, which is expected to dominate the pharmaceutical services outsourcing market in 2025.

In 2013, the U.S. FDA revised the guidelines for registration trials of drugs used in the treatment of acute bacterial skin and skin structure infections, thereby promoting growth of regulatory affairs services.

Other services such as contract manufacturing, product upgrade, and IT consulting services are projected to grow swiftly. Increasing focus on generic medicine and regional expansions in developing regions are some of the key contributing factors

Presence of cheap labor, skilled personnel and rapid growth of the pharmaceutical industry within the Asia Pacific region presents numerous opportunities for service providers, thereby representing a lucrative growth rate over the forecast period.

Service based expertise may be found in players such QuintilesIMS, Parexel Corporation, Lachman Consultant Services, Inc., Concept Heidelberg GmbH, and others. These players compete on the basis of service quality, competitive pricing, and long-term relations with healthcare industry participants.
READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Concept Heidelberg GmbH
  • Management Forum
  • Quality Context Ltd.
  • QuintilesIMS
  • The Quantic Group
  • MORE

1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
1.3 Country wise market calculation

2 Executive Summary
2.1 Market Snapshot

3 Pharmaceutical/Biotechnology Services Outsourcing Market Variables, Trends, & Scope
3.1 Market Segmentation & Scope
3.2 Market size and growth prospects
3.3 Market driver analysis
3.4 Market restraint analysis
3.5 Key Opportunities Prioritized
3.6 Industry Analysis Porter’s
3.7 Pharmaceutical/biotechnology services outsourcing PESTEL Analysis
3.8 Service pricing analysis

4 Pharmaceutical/Biotechnology Services Outsourcing Market: Service Estimates & Trend Analysis
4.1 Pharmaceutical/biotechnology services outsourcing market: Service movement analysis
4.2 Consulting services
4.2.1 Consulting services market, 2014 - 2025 (USD Million)
4.2.2 Regulatory compliance
4.2.2.1 Regulatory compliance based consulting services market, 2014 - 2025 (USD Million)
4.2.3 Remediation
4.2.3.1 Remediation based consulting services market, 2014 - 2025 (USD Million)
4.2.4 Quality management
4.2.4.1 Quality management based consulting services market, 2014 - 2025 (USD Million)
4.2.5 Other
4.2.5.1 Other consulting services market, 2014 - 2025 (USD Million)
4.3 Auditing & assessment
4.3.1 Auditing & assessment services market, 2014 - 2025 (USD Million)
4.4 Regulatory affairs services
4.4.1 Regulatory affairs services market, 2014 - 2025 (USD Million)
4.4.2 Clinical trial applications & product registration
4.4.2.1 Clinical trial application & product registration based regulatory affairs services market, 2014 - 2025 (USD Million)
4.4.3 Regulatory writing & publishing
4.4.3.1 Regulatory writing & publishing based regulatory affairs services market, 2014 - 2025 (USD Million)
4.4.4 Legal representation
4.4.4.1 Legal representation based regulatory affairs services market, 2014 - 2025 (USD Million)
4.4.5 Other
4.4.5.1 Other regulatory affairs services market, 2014 - 2025 (USD Million)
4.5 Product maintenance services
4.5.1 Product maintenance services market, 2014 - 2025 (USD Million)
4.6 Product design & development
4.6.1 Product design & development services market, 2014 - 2025 (USD Million)
4.7 Product testing & validation
4.7.1 Product testing & validation services market, 2014 - 2025 (USD Million)
4.8 Training & education
4.8.1 Training & education services market, 2014 - 2025 (USD Million)
4.9 Other services
4.9.1 Other services market, 2014 - 2025 (USD Million)

5 Pharmaceutical/Biotechnology Services Outsourcing Market: Regional Estimates & Trend Analysis
5.1 Pharmaceutical/biotechnology services outsourcing Market Share by Region, 2015 & 2025
5.2 North America
5.2.1 North America pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 - 2025
5.2.2 U.S.
5.2.2.1 U.S. pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 - 2025
5.2.3 Canada
5.2.3.1 Canada pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 - 2025
5.3 Europe
5.3.1 Europe pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 - 2025
5.3.2 UK
5.3.2.1 UK pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 - 2025
5.3.3 Germany
5.3.3.1 Germany pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 - 2025
5.4 Asia Pacific
5.4.1 Asia Pacific pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 - 2025
5.4.2 Japan
5.4.2.1 Japan pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 - 2025
5.4.3 China
5.4.3.1 China pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 - 2025
5.5 Latin America
5.5.1 Latin America pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 - 2025
5.5.2 Brazil
5.5.2.1 Brazil pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 - 2025
5.5.3 Mexico
5.5.3.1 Mexico pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 - 2025
5.6 MEA
5.6.1 MEA pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 - 2025
5.6.2 South Africa
5.6.2.1 South Africa pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 - 2025

6 Competitive Landscape
6.1 Strategy framework
6.2 Company Profiles
6.2.1 The Quantic Group
6.2.1.1 Company Overview
6.2.1.2 Financial performance
6.2.1.3 Geographic foothold
6.2.1.4 Product Benchmarking
6.2.2 QuintilesIMS
6.2.2.1 Company Overview
6.2.2.2 Financial Performance
6.2.2.3 Geographic foothold
6.2.2.4 Product Benchmarking
6.2.2.5 Strategic Initiatives
6.2.3 Parexel International Corporation
6.2.3.1 Company Overview
6.2.3.2 Financial Performance
6.2.3.3 Geographic foothold
6.2.3.4 Service Benchmarking
6.2.3.5 Strategic Initiatives
6.2.4 Lachman Consultant Services, Inc.
6.2.4.1 Company Overview
6.2.4.2 Financial performance
6.2.4.3 Geographic foothold
6.2.4.4 Product Benchmarking
6.2.4.5 Strategic Initiatives
6.2.5 GMP Pharmaceuticals Pty Ltd.
6.2.5.1 Company Overview
6.2.5.2 Geographic foothold
6.2.5.3 Geographic foothold
6.2.5.4 Product Benchmarking
6.2.5.5 Strategic Initiatives
6.2.6 Management Forum
6.2.6.1 Company overview
6.2.6.2 Financial performance
6.2.6.3 Geographic foothold
6.2.6.4 Product benchmarking
6.2.6.5 Strategic initiatives
6.2.7 Quality Context Ltd.
6.2.7.1 Company overview
6.2.7.2 Geographic foothold
6.2.7.3 Product benchmarking
6.2.7.4 Strategic initiatives
6.2.8 Inspired Pharma Training Ltd.
6.2.8.1 Company overview
6.2.8.2 Financial performance
6.2.8.3 Geographic foothold
6.2.8.4 Product benchmarking
6.2.9 Concept Heidelberg GmbH
6.2.9.1 Company overview
6.2.9.2 Financial performance
6.2.9.3 Geographic foothold
6.2.9.4 Product benchmarking
6.2.9.5 Strategic initiatives
6.2.10 Reading Scientific Services Ltd. (RSSL)
6.2.10.1 Company overview
6.2.10.2 Financial performance
6.2.10.3 Geographic foothold
6.2.10.4 Product benchmarking
6.2.10.5 Strategic initiatives

List of Tables

Table 1 Country wise market share percentage
Table 2 North America pharmaceutical/biotechnology services outsourcing market, by region, 2014 - 2025 (USD Million)
Table 3 North America pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
Table 4 North America pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
Table 5 North America pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
Table 6 U.S. pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
Table 7 U.S. pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
Table 8 U.S. pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
Table 9 Canada pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
Table 10 Canada pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
Table 11 Canada pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
Table 12 Europe pharmaceutical/biotechnology services outsourcing market, by region, 2014 - 2025 (USD Million)
Table 13 Europe pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
Table 14 Europe pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
Table 15 Europe pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
Table 16 UK pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
Table 17 UK pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
Table 18 UK pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
Table 19 Germany pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
Table 20 Germany pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
Table 21 Germany pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
Table 22 Asia Pacific pharmaceutical/biotechnology services outsourcing market, by region, 2014 - 2025 (USD Million)
Table 23 Asia Pacific pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
Table 24 Asia Pacific pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
Table 25 Asia Pacific pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
Table 26 Japan pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
Table 27 Japan pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
Table 28 Japan pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
Table 29 China pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
Table 30 China pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
Table 31 China pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
Table 32 Latin America pharmaceutical/biotechnology services outsourcing market, by region, 2014 - 2025 (USD Million)
Table 33 Latin America pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
Table 34 Latin America pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
Table 35 Latin America pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
Table 36 Brazil pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
Table 37 Brazil pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
Table 38 Brazil pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
Table 39 Mexico pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
Table 40 Mexico pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
Table 41 Mexico pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
Table 42 MEA pharmaceutical/biotechnology services outsourcing market, by region, 2014 - 2025 (USD Million)
Table 43 MEA pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
Table 44 MEA pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
Table 45 MEA pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
Table 46 South Africa pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
Table 47 South Africa pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
Table 48 South Africa pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)

List of Figures

Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value chain based sizing & forecasting
Figure 6 QFD modeling for market share assessment
Figure 7 Market summary, 2015 (USD Million)
Figure 8 Market trends & outlook
Figure 9 Pharmaceutical/biotechnology services outsourcing market: Market segmentation
Figure 10 Pharmaceutical/biotechnology services outsourcing market revenue, (USD Million), 2014-2025
Figure 11 Market driver relevance analysis (Current & future impact)
Figure 12 Increasing number of the FDA approved NME, 2008-2014
Figure 13 Number of mergers and acquisition vs value (USD Billion), 2010-2014
Figure 14 Average cost per new drug development, 2000 – 2011 (USD Million)
Figure 15 Failure rates in phase transitions during biopharmaceutical development
Figure 16 Market restraint relevance analysis (Current & future impact)
Figure 17 Key Opportunities Prioritized
Figure 18 Pharmaceutical/biotechnology services outsourcing: Porter’s analysis
Figure 19 Pharmaceutical/biotechnology services outsourcing PESTEL analysis
Figure 20 Pharmaceutical/biotechnology services outsourcing market service outlook key takeaways
Figure 21 Pharmaceutical/biotechnology services outsourcing market: Service movement analysis
Figure 22 Consulting services market, 2014 – 2025 (USD Million)
Figure 23 Regulatory compliance based consulting services market, 2014 – 2025 (USD Million)
Figure 24 Remediation based consulting services market, 2014 – 2025 (USD Million)
Figure 25 Quality management based consulting services market, 2014 – 2025 (USD Million)
Figure 26 Other consulting services market, 2014 – 2025 (USD Million)
Figure 27 Auditing & assessment services market, 2014 – 2025 (USD Million)
Figure 28 Regulatory affairs services market, 2014 – 2025 (USD Million)
Figure 29 Clinical trial application & product registration based regulatory affairs services market, 2014 – 2025 (USD Million)
Figure 30 Regulatory writing & publishing based regulatory affairs services market, 2014 – 2025 (USD Million)
Figure 31 Legal representation based regulatory affairs services market, 2014 – 2025 (USD Million)
Figure 32 Other regulatory affairs services market, 2014 – 2025 (USD Million)
Figure 33 Product maintenance services market, 2014 – 2025 (USD Million)
Figure 34 Product design & development services market, 2014 – 2025 (USD Million)
Figure 35 Product testing & validation services market, 2014 – 2025 (USD Million)
Figure 36 Training & education services market, 2014 – 2025 (USD Million)
Figure 37 Other services market, 2014 – 2025 (USD Million)
Figure 38 Regional market place: Key takeaways
Figure 39 Regional outlook, 2015 & 2025
Figure 40 North America pharmaceutical/biotechnology services outsourcing market, 2014 – 2025 (USD Million)
Figure 41 U.S. pharmaceutical/biotechnology services outsourcing market, 2014 – 2025 (USD Million)
Figure 42 Canada pharmaceutical/biotechnology services outsourcing market, 2014 – 2025 (USD Million)
Figure 43 Europe pharmaceutical/biotechnology services outsourcing market, 2014 – 2025 (USD Million)
Figure 44 UK pharmaceutical/biotechnology services outsourcing market, 2014 – 2025 (USD Million)
Figure 45 Germany pharmaceutical/biotechnology services outsourcing market, 2014 – 2025 (USD Million)
Figure 46 Asia Pacific pharmaceutical/biotechnology services outsourcing market, 2014 – 2025 (USD Million)
Figure 47 Japan pharmaceutical/biotechnology services outsourcing market, 2014 – 2025 (USD Million)
Figure 48 China pharmaceutical/biotechnology services outsourcing market, 2014 – 2025 (USD Million)
Figure 49 Latin America pharmaceutical/biotechnology services outsourcing market, 2014 – 2025 (USD Million)
Figure 50 Brazil pharmaceutical/biotechnology services outsourcing market, 2014 – 2025 (USD Million)
Figure 51 Mexico pharmaceutical/biotechnology services outsourcing market, 2014 – 2025 (USD Million)
Figure 52 MEA pharmaceutical/biotechnology services outsourcing market, 2014 – 2025 (USD Million)
Figure 53 South Africa pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
Figure 54 Strategy framework
Figure 28 Pharmaceutical/biotechnology services outsourcing market: Service movement analysis
Figure 29 Consulting services market, 2014 - 2025 (USD Million)
Figure 30 Regulatory compliance based consulting services market, 2014 - 2025 (USD Million)
Figure 31 Remediation based consulting services market, 2014 - 2025 (USD Million)
Figure 32 Quality management based consulting services market, 2014 - 2025 (USD Million)
Figure 33 Other consulting services market, 2014 - 2025 (USD Million)
Figure 34 Auditing & assessment services market, 2014 - 2025 (USD Million)
Figure 35 Regulatory affairs services market, 2014 - 2025 (USD Million)
Figure 36 Clinical trial application & product registration based regulatory affairs services market, 2014 - 2025 (USD Million)
Figure 37 Regulatory writing & publishing based regulatory affairs services market, 2014 - 2025 (USD Million)
Figure 38 Legal representation based regulatory affairs services market, 2014 - 2025 (USD Million)
Figure 39 Other regulatory affairs services market, 2014 - 2025 (USD Million)
Figure 40 Product maintenance services market, 2014 - 2025 (USD Million)
Figure 41 Product design & development services market, 2014 - 2025 (USD Million)
Figure 42 Product testing & validation services market, 2014 - 2025 (USD Million)
Figure 43 Training & education services market, 2014 - 2025 (USD Million)
Figure 44 Other services market, 2014 - 2025 (USD Million)
Figure 45 Regional market place: Key takeaways
Figure 46 Regional outlook, 2015 & 2025
Figure 47 North America pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
Figure 48 U.S. pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
Figure 49 Canada pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
Figure 50 Europe pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
Figure 51 UK pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
Figure 52 Germany pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
Figure 53 Asia Pacific pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
Figure 54 Japan pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
Figure 55 China pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
Figure 56 Latin America pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
Figure 57 Brazil pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
Figure 58 Mexico pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
Figure 59 MEA pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
Figure 60 South Africa pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
Figure 61 Strategy framework
Figure 62 Global presence of The Quantic Group
Figure 63 SWOT Analysis
Figure 64 Global presence of QuintilesIMS
Figure 65 SWOT Analysis
Figure 66 Global presence of Parexel International Corporation
Figure 67 SWOT Analysis
Figure 68 Global presence of Lachman Consultant Services, Inc.
Figure 69 SWOT Analysis
Figure 70 Global presence of GMP Pharmaceuticals Pty Ltd.
Figure 71 SWOT Analysis
Figure 72 Global presence of Management Forum
Figure 73 SWOT analysis
Figure 74 Global presence of Quality Context Ltd.
Figure 75 SWOT analysis
Figure 76 Global presence of Inspired Pharma
Figure 77 SWOT analysis
Figure 78 Global presence of Concept Heidelberg GmbH
Figure 79 SWOT analysis
Figure 80 Global presence of RSSL
Figure 81 SWOT analysis

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
  • The Quantic Group
  • QuintilesIMS
  • Parexel International Corporation
  • Lachman Consultant Services, Inc.
  • GMP Pharmaceuticals Pty Ltd.
  • Management Forum
  • Quality Context Ltd.
  • Inspired Pharma Training Ltd.
  • Concept Heidelberg GmbH
  • Reading Scientific Services Ltd. (RSSL)
Note: Product cover images may vary from those shown
5 of 6
The methodology is available for download below.
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll